These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 9875045

  • 1. Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis.
    Ramsden WH, Moya EF, Littlewood JM.
    Arch Dis Child; 1998 Oct; 79(4):339-43. PubMed ID: 9875045
    [Abstract] [Full Text] [Related]

  • 2. Fibrosing colonopathy in children with cystic fibrosis.
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S11-29. PubMed ID: 8869179
    [No Abstract] [Full Text] [Related]

  • 3. Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis.
    Connett GJ, Lucas JS, Atchley JT, Fairhurst JJ, Rolles CJ.
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):181-3. PubMed ID: 10102230
    [Abstract] [Full Text] [Related]

  • 4. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC, Burkhart GA, Borowitz D, Grand RJ, Hammerstrom T, Durie PR, Lloyd-Still JD, Lowenfels AB.
    N Engl J Med; 1997 May 01; 336(18):1283-9. PubMed ID: 9113931
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pancreatic enzymes and Fibrosing Colonopathy.
    Dodge JA.
    J Cyst Fibros; 2015 Jan 01; 14(1):153. PubMed ID: 25242743
    [No Abstract] [Full Text] [Related]

  • 9. Sonographic evaluation of bowel wall thickness in patients with cystic fibrosis.
    Dialer I, Hundt C, Bertele-Harms RM, Harms HK.
    J Clin Gastroenterol; 2003 Jul 01; 37(1):55-60. PubMed ID: 12811210
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.
    Pettei MJ, Leonidas JC, Levine JJ, Gorvoy JD.
    J Pediatr; 1994 Oct 01; 125(4):587-9. PubMed ID: 7931879
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative and experimental pathology of fibrosing colonopathy.
    van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV.
    Postgrad Med J; 1996 Mar 01; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182
    [Abstract] [Full Text] [Related]

  • 17. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
    Morrison G, Morrison JM, Redmond AO, Byers CA, McCracken KJ, Dodge JA, Guilford SA, Bowden MW.
    Aliment Pharmacol Ther; 1992 Oct 01; 6(5):549-55. PubMed ID: 1420747
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
    Zsíros J, Sólyom E.
    Orv Hetil; 1988 May 08; 129(19):995-9. PubMed ID: 3290773
    [No Abstract] [Full Text] [Related]

  • 20. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements.
    Croft NM, Marshall TG, Ferguson A.
    Lancet; 1995 Nov 11; 346(8985):1265-7. PubMed ID: 7475719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.